Cherry-red spot myoclonus syndrome (type I sialidosis)

Dev Neurosci. 1991;13(4-5):320-6. doi: 10.1159/000112180.

Abstract

The authors report the sequence of the clinical symptoms in type I sialidosis or cherry-red spot myoclonus syndrome, derived from the cases personally observed and from the literature. They also report neuropathological and neurochemical data. A serial EEG study in a case shows the tendency to a progressive deregulation of cerebral electric activity. Therapeutic attempts to reduce myoclonus, which is one of the more disabling symptoms in this syndrome, are described.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Anticonvulsants / therapeutic use
  • Brain / pathology
  • Child
  • Electroencephalography
  • Epilepsies, Myoclonic / drug therapy
  • Epilepsies, Myoclonic / etiology*
  • Epilepsies, Myoclonic / pathology
  • Fundus Oculi*
  • Humans
  • Liver / pathology
  • Lysosomal Storage Diseases* / complications
  • Lysosomal Storage Diseases* / enzymology
  • Lysosomal Storage Diseases* / pathology
  • Lysosomal Storage Diseases* / urine
  • Neuraminidase / deficiency*
  • Oligosaccharides / urine
  • Syndrome

Substances

  • Anticonvulsants
  • Oligosaccharides
  • sialooligosaccharides
  • Neuraminidase